We are one of only a few hospitals in the country offering a relatively new treatment option, called UroLift®, for men with benign prostatic hyperplasia (BPH).
The UroLift® system received NICE guidance approval in 2014, as a proven surgical option for the treatment of lower urinary tract symptoms due to an enlarged prostate due to BPH. The treatment works by using a number of tiny implants to lift and hold the enlarged prostate tissue out of the way so that it no longer blocks the urethra, resulting in improved urine flow.
UroLift® is unique in that it does not destroy the prostate tissue, meaning that it does not cause erectile dysfunction or permanent urinary incontinence. It is a minimally invasive procedure which can means patients can return home and to normal daily activities soon after treatment.
For men older than 50 years, benign prostatic hyperplasia (BPH) is a common prostate problem. UroLift® is an alternative for patients looking for something other than drug therapy or more invasive surgery. Treatment might be right for you if any of the following apply to you:
Typically you will be able to go home after the procedure without a catheter. You should experience rapid symptom relief without complications, as early as two weeks after the procedure. Results are long-lasting, with no medications required to sustain relief.
We offer competitive all-inclusive package prices making it easy to pay for your own treatment.
We have agreements in place with all of the major health insurance providers. So, if you are insured, please call your insurance company for authorisation.
More than two or three infections a year is viewed as ‘recurrent’ infections. If you are getting lots of infections then some simple tests can exclude any underlying abnormalities that are making them occur more often.
Surgery that involves cutting both the tubes (vas) that carry sperm from the testicles.
Prostate Mapping (also known as Transperineal template biopsy) is a diagnostic procedure to find out if a patient has prostate cancer.
Will Quince, Conservative MP for Colchester and former Minister of State for Health recently visited Oaks Hospital in Colchester to see how Ramsay Health Care UK is delivering high quality healthcare for local patients.
On Tuesday 30th August Oaks Hospital hosted the official opening of its brand new SACT (Systemic Anti-Cancer Therapy) unit, which offers oncology services to patients for a range of specialty areas including skin, gynaecology, urology and breast cancers in the local area.
Oaks Hospital is celebrating after being named as a National Joint Registry (NJR) Quality Data Provider after successfully completing a national programme of local data audits.